Advancing Automatic Gastritis Diagnosis: an Interpretable Multilabel Deep Learning Framework for the Simultaneous Assessment of Multiple Indicators
Mengke Ma,Xixi Zeng,Linhao Qu,Xia Sheng,Hongzheng Ren,Weixiang Chen,Bin Li,Qinghua You,Li Xiao,Yi Wang,Mei Dai,Boqiang Zhang,Changqing Lu,Weiqi Sheng,Dan Huang
DOI: https://doi.org/10.1016/j.ajpath.2024.04.007
IF: 5.77
2024-01-01
American Journal Of Pathology
Abstract:The evaluation of morphologic features, such as inflammation, fl ammation, gastric atrophy, and intestinal metaplasia, is crucial for diagnosing gastritis. However, artificial fi cial intelligence analysis for nontumor diseases like gastritis is limited. Previous deep learning models have omitted important morphologic indicators and cannot simultaneously diagnose gastritis indicators or provide interpretable labels. To address this, an attention-based multi-instance multilabel learning network (AMMNet) was developed to simultaneously achieve the multilabel diagnosis of activity, atrophy, and intestinal metaplasia with only slide- level weak labels. To evaluate AMMNet's real-world performance, a diagnostic test was designed to observe improvements in junior pathologists' diagnostic accuracy and efficiency fi ciency with and without AMMNet assistance. In this study of 1096 patients from seven independent medical centers, AMMNet performed well in assessing activity [area under the curve (AUC), 0.93], atrophy (AUC, 0.97), and intestinal metaplasia (AUC, 0.93). The false-negative rates of these indicators were only 0.04, 0.08, and 0.18, respectively, and junior pathologists had lower false-negative rates with model assistance (0.15 versus 0.10). Furthermore, AMMNet reduced the time required per whole slide image from 5.46 to 2.85 minutes, enhancing diagnostic efficiency. fi ciency. In block-level clustering analysis, AMMNet effectively visualized task-related patches within whole slide images, improving interpretability. These fi ndings highlight AMMNet's effectiveness in accurately evaluating gastritis morphologic indicators on multicenter data sets. Using multi-instance multilabel learning strategies to support routine diagnostic pathology deserves further evaluation. (Am J Pathol 2024, 194: 1538e1549; e 1549; https://doi.org/10.1016/ j.ajpath.2024.04.007)